These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11196593)
1. [Indications for the pharmacologic treatment of hyperlipidemias]. Cía Gómez P Rev Clin Esp; 2000 Nov; 200(11):622-5. PubMed ID: 11196593 [No Abstract] [Full Text] [Related]
2. Should we treat all primary prevention patients with statins? Guthrie R Curr Atheroscler Rep; 2009 Jan; 11(1):36-42. PubMed ID: 19080726 [TBL] [Abstract][Full Text] [Related]
3. [Drug combination therapies for patients with hyperlipidemia and its significance]. Onuma T; Kawamori R Nihon Rinsho; 2001 Mar; 59 Suppl 3():566-71. PubMed ID: 11347133 [No Abstract] [Full Text] [Related]
16. The pharmacology and therapeutics of lipid-lowering drugs. Hunninghake DB Am Pharm; 1987 Nov; NS27(11):S18-25. PubMed ID: 3425537 [No Abstract] [Full Text] [Related]
17. Niacin in cardiovascular patients receiving statins. Brouwers MC; Stehouwer CD N Engl J Med; 2012 Mar; 366(13):1255; author reply 1255-6. PubMed ID: 22455426 [No Abstract] [Full Text] [Related]
18. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]
19. Niacin at 56 years of age--time for an early retirement? Giugliano RP N Engl J Med; 2011 Dec; 365(24):2318-20. PubMed ID: 22085318 [No Abstract] [Full Text] [Related]